Hypertrophic cardiomyopathy_HCM

Gene: TULP3

Amber List (moderate evidence)

TULP3 (tubby like protein 3)
EnsemblGeneIds (GRCh38): ENSG00000078246
EnsemblGeneIds (GRCh37): ENSG00000078246
OMIM: 604730, Gene2Phenotype
TULP3 is in 5 panels

3 reviews

Bryony Thompson (Royal Melbourne Hospital)

Comment on list classification: Currently, only 3 adult individuals from 2 unrelated families presented with hypertrophic non-obstructive cardiomyopathy (HNCM). More evidence required for the HCM association
Created: 22 Aug 2024, 8:24 a.m. | Last Modified: 22 Aug 2024, 8:24 a.m.
Panel Version: 0.182

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Green List (high evidence)

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Hepatorenocardiac degenerative fibrosis, MIM# 619902

Anna Ritchie (Victorian Clinical Genetics Services)

Green List (high evidence)

15 individuals from eight unrelated families with bi-allelic variants in TULP3 were detected. The affected individuals reported are mostly adults, in the 3rd through 7th decades of life, and presented with progressive degenerative liver fibrosis with variable fibrocystic kidney disease and hypertrophic cardiomyopathy.

The human phenotype was ecapitulated in adult zebrafish and confirmed disruption of critical ciliary cargo composition in several primary cell lines derived from affected individuals
Sources: Literature
Created: 5 May 2022, 1:50 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
progressive degenerative liver fibrosis with variable fibrocystic kidney disease; hypertrophic cardiomyopathy MONDO:0005045

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Amber
Phenotypes
  • Hepatorenocardiac degenerative fibrosis, MIM# 619902
OMIM
604730
Clinvar variants
Variants in TULP3
Penetrance
None
Publications
Panels with this gene

History Filter Activity

22 Aug 2024, Gel status: 2

Entity classified by Genomics England curator

Bryony Thompson (Royal Melbourne Hospital)

Gene: tulp3 has been classified as Amber List (Moderate Evidence).

29 May 2022, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: TULP3 were changed from progressive degenerative liver fibrosis with variable fibrocystic kidney disease; hypertrophic cardiomyopathy MONDO:0005045 to Hepatorenocardiac degenerative fibrosis, MIM# 619902

5 May 2022, Gel status: 3

Entity classified by Genomics England curator

Alison Yeung (Victorian Clinical Genetics Services)

Gene: tulp3 has been classified as Green List (High Evidence).

5 May 2022, Gel status: 3

Entity classified by Genomics England curator

Alison Yeung (Victorian Clinical Genetics Services)

Gene: tulp3 has been classified as Green List (High Evidence).

5 May 2022, Gel status: 3

Entity classified by Genomics England curator

Alison Yeung (Victorian Clinical Genetics Services)

Gene: tulp3 has been classified as Green List (High Evidence).

5 May 2022, Gel status: 0

Entity classified by Genomics England curator

Alison Yeung (Victorian Clinical Genetics Services)

Gene: tulp3 has been removed from the panel.

5 May 2022, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Anna Ritchie (Victorian Clinical Genetics Services)

gene: TULP3 was added gene: TULP3 was added to Hypertrophic cardiomyopathy_HCM. Sources: Literature Mode of inheritance for gene: TULP3 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TULP3 were set to PMID: 35397207 Phenotypes for gene: TULP3 were set to progressive degenerative liver fibrosis with variable fibrocystic kidney disease; hypertrophic cardiomyopathy MONDO:0005045